Abstract
Endometriosis is a prevalent, complex, inflammatory condition associated with a diverse range of symptoms and comorbidities. Despite its substantial burden on patients, population-level studies that explore its comorbid patterns and heterogeneity are limited. In this retrospective case-control study, we analyzed comorbidities from over forty thousand endometriosis patients across six University of California medical centers using de-identified electronic health record (EHR) data. We found hundreds of conditions significantly associated with endometriosis, including genitourinary disorders, neoplasms, and autoimmune diseases, with strong replication across datasets. Clustering analyses identified patient subpopulations with distinct comorbidity patterns, including psychiatric and autoimmune conditions. This study provides a comprehensive analysis of endometriosis comorbidities and highlights the heterogeneity within the patient population. Our findings demonstrate the utility of EHR data in uncovering clinically meaningful patterns and suggest pathways for personalized disease management and future research on biological mechanisms underlying endometriosis.
Competing Interest Statement
L.C.G. is a consultant to Myovant Sciences, Gensyta Pharma, Celmatix, NextGen Jane, and Chugai Pharmaceutical Co. The remaining authors declare no competing interests.
Funding Statement
This manuscript was supported by the Eunice Kennedy Shriver National Institute for Child Health and Human Development, P01HD106414 (UK, TTO, JCI, JO, LCG, MS), and the National Institute of General Medical Sciences, T32GM067547 (UK) and T32GM142516 (KG).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All analysis of University of California electronic health record data was performed under the approval of the Institutional Review Board from the University of California, San Francisco. All clinical data were de-identified and written informed consent was waived by the institution.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
References to specific University of California locations have been removed.
Data Availability
The data that support the findings of this study are not openly available to individuals unaffiliated with UCSF due to the sensitivity of medical records, with the exception of collaborators. Individuals not affiliated with UCSF may set up an official collaboration with a UCSF-affiliated investigator by reaching out to the lead contact, Marina Sirota (marina.sirota{at}ucsf.edu). UCSF-affiliated individuals may contact UCSF’s Clinical and Translational Science Institute (ctsi{at}ucsf.edu) or the UCSF’s Information Commons team for more information (info.commons{at}ucsf.edu). UC-wide data is only available to UC researchers who have completed analyses in their respective UC first and have provided justification for scaling their analyses across UC health centers. Censored code for the analysis and visualizations in this study can be found at https://github.com/khanu263/comorbidities-clustering-endo.
